Correlation Between Enliven Therapeutics and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Enliven Therapeutics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Sonnet Biotherapeutics.
Diversification Opportunities for Enliven Therapeutics and Sonnet Biotherapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Sonnet is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Sonnet Biotherapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.72 times more return on investment than Sonnet Biotherapeutics. However, Enliven Therapeutics is 1.39 times less risky than Sonnet Biotherapeutics. It trades about -0.19 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.61 per unit of risk. If you would invest 2,785 in Enliven Therapeutics on September 1, 2024 and sell it today you would lose (347.00) from holding Enliven Therapeutics or give up 12.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Enliven Therapeutics |
| Sonnet Biotherapeutics |
Enliven Therapeutics and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Sonnet Biotherapeutics
The main advantage of trading using opposite Enliven Therapeutics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| Sonnet Biotherapeutics vs. Tff Pharmaceuticals | Sonnet Biotherapeutics vs. Eliem Therapeutics | Sonnet Biotherapeutics vs. Inhibrx | Sonnet Biotherapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |